Emerging opportunities in the C5 inhibitor market include advances in biosuperiors and biosimilars, targeting a range of C5-mediated diseases such as PNH and aHUS. Innovations focus on enhancing ...
The complement cascade, a proteolytic network originally characterised for host defence, exerts multifaceted roles within the central nervous system. Under physiological conditions, complement ...
InflaRx intends to develop izicopan in ANCA-associated vasculitis (AAV), with a secondary goal of establishing rapid proof of concept in ...
White blood cells called neutrophils act as factories for C4A, linking peripheral immunity to schizophrenia and synaptic ...
The most common white blood cells in your body—immune cells called neutrophils—can make a protein nobody knew they were ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will publish its financial and ...
AstraZeneca to showcase phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026: Cambridge, UK Monday, May 25, 2026, 12: ...
A new study found that immune cells called neutrophils may contribute to schizophrenia by generating and activating the ...
Jelly Tide Supplement Facts, ACV and BHB Gummy Ingredients, Metabolic Support, Side Effects, Scam or Legit, FDA, and Refund Policy for Digestion ...
Zensulin is a dietary supplement. Dietary supplements are not FDA-approved to diagnose, treat, cure, or prevent disease. The ...
Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.